Catalyst Wire Dossier Catalyst Wire Dossier

Tenofovir alafenamide (TAF)

Tenofovir alafenamide
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Tenofovir alafenamide (TAF), covering 2019-09-25 to 2021-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir. [Phase 4]

See pricing